Diagnostic Criteria of ARDS at High Altitudes in Western China

  • STATUS
    Recruiting
  • participants needed
    3000
  • sponsor
    Affiliated Hospital of Qinghai University
Updated on 16 February 2024
aspiration
shock
pneumonia
positive end expiratory pressure
systemic infection
primary disease
aspiration pneumonitis

Summary

The severity of ARDS in high altitude areas was classified according to the Berlin standard high altitude area Oxygenation.

Description

Will between January 2018 and December 2018 in lanzhou, and so on more than 1500 meters above sea level in qinghai region 10 intensive care patients with ARDS, respectively according to the standard in Berlin, Berlin, diagnosis of high altitude ARDS calibration standards and zhang the plateau region in western China put forward by the diagnosis of ALI/ARDS severity classification, observation group patients were ICU mortality, within 28 days, ICU mortality did not use breathing machine time, mechanical ventilation, ICU length of hospital stay, and the differences in hospitalization days.

Details
Condition ADULT RESPIRATORY DISTRESS SYNDROME
Age 18years - 100years
Clinical Study IdentifierNCT04215666
SponsorAffiliated Hospital of Qinghai University
Last Modified on16 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

age 18
the primary disease of ARDS caused by systemic infection, shock, severe pneumonia, aspiration and trauma
blood gas analysis showed a progressive decline in pulmonary ventilation function

Exclusion Criteria

Receive a large amount of hormone shock therapy in a short period of time
Died within a short time (< 24h) after mechanical ventilation
Lack of data
No chest imaging data
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.